Lexicon Pharmaceuticals, Inc. (LXRX)

Lexicon Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	62.89	66.66	22.47	46.35	64.07	126.26
Short-Term Investments	131.95	171.3	147.56	92.01	22.68	26.01
Cash & Short-Term Investments	194.84	237.96	170.03	138.36	86.74	152.28
Cash Growth	-45.21%	39.95%	22.89%	59.50%	-43.04%	-43.95%
Receivables	47.45	3.47	1.01	0.03	0.01	0.4
Inventory	0.2	0.23	0.38	-	-	-
Prepaid Expenses	3.32	4.53	5.13	2.48	2.16	5.05
Total Current Assets	245.81	246.19	176.55	140.87	88.92	157.72
Property, Plant & Equipment	6.95	7.32	7.51	8.48	3.45	1.53
Goodwill	44.54	44.54	44.54	44.54	44.54	44.54
Other Long-Term Assets	0.37	0.37	0.83	0.41	-	-
Total Assets	297.67	298.42	229.43	194.3	136.91	203.79
Accounts Payable	10.69	14.8	14.39	10.4	9.15	5.47
Accrued Expenses	11.9	29.27	15.87	11.49	11.88	29.14
Current Portion of Long-Term Debt	42.06	-	-	-	-	11.65
Current Portion of Leases	1.04	1.18	1.29	1.29	1.09	0.55
Current Unearned Revenue	45	-	-	-	-	-
Total Current Liabilities	110.69	45.25	31.55	23.17	22.12	46.81
Long-Term Debt	58.64	100.3	99.51	48.58	-	-
Long-Term Leases	4.52	4.6	5.27	5.42	1.19	0.61
Other Long-Term Liabilities	0.78	2.32	-	-	-	-
Total Liabilities	174.64	152.47	136.32	77.18	23.31	47.42
Common Stock	0.37	0.36	0.25	0.19	0.15	0.14
Additional Paid-In Capital	2,120	2,117	1,863	1,709	1,609	1,561
Retained Earnings	-1,993	-1,967	-1,767	-1,590	-1,488	-1,400
Treasury Stock	-5.19	-4.62	-2.89	-2.06	-7.52	-4.84
Comprehensive Income & Other	0.03	0.12	0.03	-0.43	-0.01	-0.01
Shareholders' Equity	123.03	145.95	93.11	117.12	113.6	156.37
Total Liabilities & Equity	297.67	298.42	229.43	194.3	136.91	203.79
Total Debt	106.26	106.07	106.06	55.29	2.28	12.81
Net Cash (Debt)	88.58	131.88	63.96	83.06	84.46	139.47
Net Cash Growth	-64.48%	106.19%	-23.00%	-1.66%	-39.44%	461.88%
Net Cash Per Share	0.25	0.41	0.29	0.50	0.58	1.26
Filing Date Shares Outstanding	363.18	361.49	246.24	188.73	149.59	143.56
Total Common Shares Outstanding	363.18	361.49	244.92	188.73	148.92	141.5
Working Capital	135.11	200.95	145	117.69	66.8	110.91
Book Value Per Share	0.34	0.40	0.38	0.62	0.76	1.11
Tangible Book Value	78.49	101.41	48.57	72.58	69.05	111.83
Tangible Book Value Per Share	0.22	0.28	0.20	0.38	0.46	0.79
Machinery	2.39	2.39	4.35	4	4.72	5.69
Leasehold Improvements	2.18	2.18	2.18	2.05	1.31	0.42

Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q